Cytosorbents Corporation
1.08
0.04 (3.85%)
At close: Jan 15, 2025, 12:04 PM

Cytosorbents Corporation Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Grant income Revenue 777.59K 1.05M 796.77K 59.33K 6.58K 3.77K 245.51K 191.47K 292.63K
Grant income Revenue Growth -26.14% +32.14% +1242.90% +801.29% +74.62% -98.46% +28.22% -34.57% n/a
Other sales Revenue 26.52K 11.40K 24.73K n/a n/a n/a n/a n/a n/a
Other sales Revenue Growth +132.68% -53.91% n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021
All Other Countries Revenue 18.05M 15.82M 17.41M
All Other Countries Revenue Growth +14.08% -9.12% n/a
Germany Revenue 12.96M n/a n/a
Germany Revenue Growth n/a n/a n/a
United States Revenue 5.26M 968.95K 1.69M
United States Revenue Growth +443.31% -42.66% n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 7.00B 7.58M 8.57M 9.24M 9.21M 8.91M 9.13M 8.71M 9.34M 9.12M 9.96M 11.08M 8.44M 10.54M 8.42M 9.38M 7.86M 7.44M 6.84M 7.21M 6.84M 5.10M 5.32M 7.16M 4.46M 6.58M 4.68M 4.77M 3.92M 3.93M 2.95M 4.69M 2.42M 2.94M 2.22M 2.37M 1.99M 1.92M 2.18M
Selling, General, and Administrative Revenue Growth +92269.51% -11.51% -7.30% +0.37% +3.36% -2.44% +4.83% -6.78% +2.48% -8.46% -10.12% +31.30% -19.91% +25.21% -10.23% +19.27% +5.72% +8.79% -5.17% +5.37% +34.18% -4.16% -25.70% +60.61% -32.27% +40.70% -1.84% +21.62% -0.23% +33.27% -37.22% +93.97% -17.81% +32.35% -6.05% +19.06% +3.35% -11.70% n/a
Research and Development Revenue 1.85B 1.52M 2.25M 4.10M 3.75M 3.67M 4.21M 3.40M 3.29M 4.18M 4.24M 6.14M 4.26M 3.70M 2.28M 2.69M 1.75M 2.41M 1.97M 3.56M 3.19M 2.93M 2.42M 2.42M 1.94M 1.58M 1.78M 2.42M 537.95K 487.61K 469.55K 1.66M 1.17M 1.09M 856.12K 1.25M 866.33K 801.66K 951.03K
Research and Development Revenue Growth +121722.06% -32.41% -45.12% +9.27% +2.19% -12.96% +23.90% +3.40% -21.35% -1.41% -30.86% +43.99% +15.22% +62.10% -15.03% +53.12% -27.10% +22.44% -44.78% +11.73% +8.72% +21.13% -0.20% +24.71% +23.33% -11.49% -26.47% +350.08% +10.32% +3.85% -71.77% +41.89% +7.33% +27.56% -31.62% +44.52% +8.07% -15.71% n/a
Sales and Marketing Revenue 6.99B -820.73K -680.71K -1.31M 49.00K 38.00K 55.00K 224.00K 143.00K 115.00K 81.00K 160.00K 151.00K 148.00K 154.00K 167.00K 32.00K 55.00K 31.50K 99.00K 70.00K 93.00K 51.80K 86.00K 40.00K 49.00K 36.76K 30.00K 45.00K 37.00K 49.76K 20.00K 28.00K 45.00K 79.61K 82.00K 84.00K 66.00K 51.00K
Sales and Marketing Revenue Growth -852374.72% +20.57% -48.22% -2782.77% +28.95% -30.91% -75.45% +56.64% +24.35% +41.98% -49.38% +5.96% +2.03% -3.90% -7.78% +421.88% -41.82% +74.60% -68.18% +41.43% -24.73% +79.54% -39.77% +115.00% -18.37% +33.29% +22.54% -33.33% +21.62% -25.65% +148.82% -28.57% -37.78% -43.47% -2.91% -2.38% +27.27% +29.41% n/a